NANOVIRICIDES, INC. business relationships

Companies named in NANOVIRICIDES, INC.’s 10-K filed 2026-09-28, and public companies whose annual reports name NANOVIRICIDES, INC.. Each link shows the sentence it came from. Scores are Engagemii’s AI visibility scores.

Open on the map Full AI visibility profile

AEO visibility: 4.7 / 10
AI naming: 12 / 100
Agent readiness: 0 / 100
AI adoption: - / 100

Named in NANOVIRICIDES, INC.’s annual report 5

Roche GroupSales channel7.7
“The current approved drugs for influenza include the neuraminidase inhibitors Tamiflu, Relenza, and Peramivir, anti-influenza drugs that are sold by Roche, Glaxo SmithKline (GSK), and BioCryst partners, respectively.” SEC filing
GSK plc (GSK)Partner5.5
“The current approved drugs for influenza include the neuraminidase inhibitors Tamiflu, Relenza, and Peramivir, anti-influenza drugs that are sold by Roche, Glaxo SmithKline (GSK), and BioCryst partners, respectively.” SEC filing
Aagami, Inc.Partner4.0
“We have begun the process of actively seeking partnerships by retaining a consulting firm, Aagami, Inc., based in Illinois.” SEC filing
Karveer Meditech Private LimitedLicensee3.5
“Out-Licensing to Karveer Meditech Private Limited, India (KMPL)” SEC filing
Karveer Meditech Private LimitedLicensor3.5
“License Agreement with Karveer Meditech Private Limited” SEC filing

Links are read automatically from SEC annual reports (10-K, 20-F, 40-F). In a hand check of random links, about 8 in 10 were real business relationships, so every link carries its source sentence.